SMTL ID : 4jve.1

Co-crystal structure of MDM2 with inhibitor (2R,3E)-2-[(2S,3R,6S)-2,3-bis(4-chlorophenyl)-6-(4-fluorobenzyl)-5-oxomorpholin-4-yl]pent-3-enoic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x 1MQ: (2R,3E)-2-[(2S,3R,6S)-2,3-BIS(4-CHLOROPHENYL)-6-(4-FLUOROBENZYL)-5-OXOMORPHOLIN-4-YL]PENT-3-ENOIC ACID(Non-covalent)

1MQ.1: 12 residues within 4Å: Chain A: L.37, F.38, L.40, G.41, Q.42, I.44, M.45, Q.54, V.76, H.79, I.82, Y.83 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.37, A:L.37, A:F.38, A:F.38, A:L.40, A:I.44, A:I.44, A:V.76, A:Y.83 Salt bridges: A:H.79

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gonzalez-Lopez de Turiso, F. et al., Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors. J.Med.Chem. (2013)

Release Date

2013-05-01

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence